Immunophenotypes of pancreatic ductal adenocarcinoma : Meta-analysis of transcriptional subtypes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1002/ijc.32186
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2019
- Urheber
-
Santiago, Ines
Yau, Christopher
Heij, Lara
Middleton, Mark R.
Markowetz, Florian
Grabsch, Heike I.
Dustin, Michael L.
Sivakumar, Shivan
- DOI
-
10.18154/RWTH-2020-02801
- URN
-
urn:nbn:de:101:1-2020111307250510601042
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Santiago, Ines
- Yau, Christopher
- Heij, Lara
- Middleton, Mark R.
- Markowetz, Florian
- Grabsch, Heike I.
- Dustin, Michael L.
- Sivakumar, Shivan
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2019
Ähnliche Objekte (12)
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
Models of pancreatic ductal adenocarcinoma
CYP3A5 as mediator of drug resistance in different subtypes of pancreatic ductal adenocarcinoma
Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
Advanced pancreatic ductal adenocarcinoma : moving forward
Apoptotic pathways in pancreatic ductal adenocarcinoma
Oral mycobiota and pancreatic ductal adenocarcinoma
CSTF2 mediated mRNA N 6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
Models of pancreatic ductal adenocarcinoma
CYP3A5 as mediator of drug resistance in different subtypes of pancreatic ductal adenocarcinoma
Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
Advanced pancreatic ductal adenocarcinoma : moving forward
Apoptotic pathways in pancreatic ductal adenocarcinoma
Oral mycobiota and pancreatic ductal adenocarcinoma
CSTF2 mediated mRNA N 6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
Models of pancreatic ductal adenocarcinoma
CYP3A5 as mediator of drug resistance in different subtypes of pancreatic ductal adenocarcinoma
Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
Advanced pancreatic ductal adenocarcinoma : moving forward
Apoptotic pathways in pancreatic ductal adenocarcinoma
Oral mycobiota and pancreatic ductal adenocarcinoma